Dr. Matthew R. Skelton, MD

  • Roanoke, VA
  • Hematologist and oncologist
NPI1689614919PAC ID8224049192
Medicare services, 2024
78,494
Medicare patients, 2024
695
Part D claims, 2024
1,327
Publications
36
MIPS score, 2024
75
Practice address
2013 S Jefferson St, Roanoke, VA 24014
Practice phone
Call (540) 982-0237
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Blue Ridge Cancer Care

Roanoke, Virginia

See all 7 affiliations

Find Dr. Skelton's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Matthew R. Skelton is a hematologist and oncologist in Roanoke, Virginia

Dr. Skelton practices at Blue Ridge Cancer Care in Roanoke, Virginia.

Dr. Skelton's NPI, 1689614919, was assigned on June 7, 2006. Dr. Skelton graduated from Jefferson Medical College of Thomas Jefferson University in 2001. Dr. Skelton holds Virginia license 0101242462.

NPI and contact details
Medicare PAC ID
8224049192
NPI enumeration date
June 7, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(540) 982-0237
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
51
Medical school graduation
2001

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Matthew R. Skelton practices at Blue Ridge Cancer Care in Roanoke, Virginia

Dr. Skelton's primary practice is Blue Ridge Cancer Care, at 2013 S Jefferson St, Roanoke, VA 24014 in Roanoke City. The practice phone is (540) 982-0237.

  • Blue Ridge Cancer Care
    2013 S Jefferson St, Roanoke, VA 24014 · Roanoke CityPhone(540) 982-0237

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Matthew R. Skelton is affiliated with 6 sites of care and 1 medical group

Dr. Skelton's primary practice is Blue Ridge Cancer Care in Roanoke, Virginia. Dr. Skelton is also affiliated with Carilion Roanoke Memorial Hospital. The medical group on file is Blue Ridge Cancer Care. Dmand AI also links Dr. Skelton to 4 more hospitals, each named with a free account.

See all 7 affiliations for Dr. Skelton

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Matthew R. Skelton's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Skelton practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Blue Ridge Cancer CareAvailable with a free account
+5 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Skelton practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Matthew R. Skelton is one of 297 hematologists and oncologists in Virginia

Hematology and oncology is Dr. Skelton's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Skelton's licenses on file in 2 states: Virginia and North Carolina.

Specialties and state licenses

  • Hematology and oncology, VirginiaPrimaryLicense 0101242462 · taxonomy 207RH0003X
  • North Carolina licenseLicense 200500613

Hematologists and oncologists near Dr. Skelton

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Matthew R. Skelton billed Medicare for 78,494 services in 2024

CMS data shows 78,494 Medicare services from Dr. Skelton across 61 procedure codes in 2024, for 695 Medicare patients. Medicare paid $1,027,072 for them.

Medicare services, 202478,494
Medicare patients695
Paid by Medicare$1M
Procedure codes61

Dr. Skelton's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 59,0292024: 69,18817%
Lab and pathology
2023: 5,1982024: 5,1431%
Tests and treatments
2023: 1,9032024: 1,9362%
Office and hospital visits
2023: 1,2092024: 94322%
Surgery
2023: 8902024: 8841%
Other services
2023: 1892024: 401112%

Where Dr. Skelton's Medicare services took place, 2024

  • In an office78,406100%
  • In a facility890%

Dr. Skelton compared with the Virginia median for hematologists and oncologists, 2024

  • Dr. Skelton
  • Virginia median
Medicare services
78,494vs 3,51422.3 times
Medicare patients
695vs 47447% above
Part D claims
962vs 4522.1 times

Medians across 275 hematologists and oncologists in Virginia with Dmand AI profiles that report each measure.

Dr. Skelton's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Skelton

Need commercial claims for Dr. Skelton?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Skelton and other hematologists and oncologists in Virginia.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Matthew R. Skelton treated 695 Medicare patients in 2024, average age 75

CMS counts 695 Medicare patients who saw Dr. Skelton in 2024. The largest group is 65 to 74, with 295 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Skelton's median patient age at 69, with 52% women.

Medicare patients, 2024695
Average age75
Average risk score2.14
Also on Medicaid8%

Dr. Skelton's Medicare patients by age, 2024

Dr. Skelton's Medicare patients by sex, 2024

  • Women34750%
  • Men34850%

Chronic conditions among Dr. Skelton's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol73%
  3. Cancer49%
  4. Arthritis47%
  5. Diabetes36%
  6. Chronic kidney disease32%
  7. Anxiety29%
  8. Ischemic heart disease27%

Share of Medicare patients with each condition. A patient can have several.

Dr. Skelton's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women52%
  • Men47%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Matthew R. Skelton wrote 1,327 Medicare Part D claims in 2024

In 2024, Dr. Skelton wrote 1,327 Medicare Part D claims for 231 patients. 74% of them were for generic drugs. CMS names the drug for 962 of them, across 35 drugs with 11 or more claims each, at $2,430,216 in total drug cost. In 2023, CMS named 1,038 claims across 33 drugs.

Part D claims, 20241,327
Drugs named by CMS35
Total drug cost$2.4M
Part D patients231

Dr. Skelton's Part D claims by kind of drug, 2024

  • Generic979 claims74%
  • Brand-name348 claims26%

Dr. Skelton's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Skelton's Part D claims, 2024

  • Opioids3%34 of 1,327 claims
  • Antibiotics2%29 of 1,327 claims
  • Antipsychotics, patients 65 and over3%34 of 1,327 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,0382024: 9627%

Drugs named by CMS: 35 in 2024, 33 in 2023.

See all prescribing by Dr. Skelton

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Matthew R. Skelton scored 75 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Skelton for performance year 2024, reported through an alternative payment model (APM). Dr. Skelton accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes
MIPS final score, 2024
75 of 100

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Skelton by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Matthew R. Skelton has 36 publications on record

Dmand AI links 36 papers to Dr. Skelton, published from 2011 to 2025. 2019 was the busiest year, with 5. The most frequent topics are Creatine, Maze Learning and Membrane Transport Proteins. Dr. Skelton has published most often in JCO Oncol Pract. Dr. Skelton's most frequent co-authors are Blase N. Polite, Neil Mark Richtand, MD and Kerin Bess Adelson, MD.

Papers36
Years published2011 to 2025

Dr. Skelton's papers by year, 2016 to 2025

Topics Dr. Skelton writes about most

  • Creatine
  • Maze Learning
  • Membrane Transport Proteins
  • Mice, Knockout
  • Brain
  • Brain Diseases, Metabolic, Inborn
  • X-Linked Intellectual Disability
  • Plasma Membrane Neurotransmitter Transport Proteins

Dr. Skelton's most frequent co-authors

Recent publications by Dr. Skelton

See all 36 publications and co-authors

See who Dr. Skelton researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Skelton works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Matthew R. Skelton received $592 in industry payments from 2016 to 2025

CMS Open Payments shows 26 general payments to Dr. Skelton from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Novartis Pharmaceuticals Corporation paid the most, $95.

General payments to Dr. Skelton by program year, 2016 to 2025

General payments to Dr. Skelton by kind, 2016 to 2025

$592in total
  • Food and beverage$51086%
  • Education$8114%

Companies that paid Dr. Skelton the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Skelton

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Matthew R. Skelton graduated from Jefferson Medical College of Thomas Jefferson University

Dr. Skelton graduated from Jefferson Medical College of Thomas Jefferson University in 2001.

  1. Medical schoolJefferson Medical College of Thomas Jefferson University

Source: Dmand AI Professional Profile Data

Sources for Dr. Matthew R. Skelton's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Matthew R. Skelton

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Matthew R. Skelton's NPI number?

Dr. Matthew R. Skelton's NPI number is 1689614919. It was assigned on June 7, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Matthew R. Skelton?

Dr. Matthew R. Skelton is a hematologist and oncologist in Roanoke, Virginia. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Matthew R. Skelton practice?

Dr. Skelton practices at 2013 S Jefferson St, Roanoke, VA 24014. Dr. Skelton's primary practice is Blue Ridge Cancer Care in Roanoke, Virginia. Dmand AI also links Dr. Skelton to 4 hospitals.

What is Dr. Matthew R. Skelton's office phone number?

The practice phone on file for Dr. Skelton is (540) 982-0237.

What is Dr. Matthew R. Skelton's medical license number?

Dr. Skelton holds Virginia license 0101242462, one of the licenses on file in 2 states.

Which states has Dr. Matthew R. Skelton been licensed in?

Dmand AI has state licenses on file for Dr. Skelton in Virginia and North Carolina.

Which hospitals is Dr. Matthew R. Skelton affiliated with?

Dr. Skelton is affiliated with Carilion Roanoke Memorial Hospital. Dmand AI links Dr. Skelton to 4 more hospitals.

What medical group is Dr. Matthew R. Skelton part of?

Dr. Skelton is linked to Blue Ridge Cancer Care.

Does Dr. Matthew R. Skelton accept Medicare?

Yes. CMS data shows Dr. Skelton billed Medicare for 78,494 services in 2024, and Dr. Skelton accepts Medicare assignment.

What is Dr. Matthew R. Skelton's MIPS score?

Dr. Skelton's MIPS final score for performance year 2024 is 75 out of 100, reported through an alternative payment model (APM).

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Matthew R. Skelton see?

CMS counts 695 Medicare patients who saw Dr. Skelton in 2024, with an average age of 75.

What services does Dr. Matthew R. Skelton bill to Medicare?

In 2024, Dr. Skelton's most billed Medicare services were injected or infused drug (J0881), injected or infused drug (J9271) and injected or infused drug (J1439).

Where did Dr. Matthew R. Skelton go to medical school?

Dr. Skelton graduated from Jefferson Medical College of Thomas Jefferson University in 2001.

What drugs does Dr. Matthew R. Skelton prescribe most?

In 2024 Medicare Part D data, Dr. Skelton's most prescribed drugs by claims were Prednisone, Abiraterone Acetate and Anastrozole.

Has Dr. Matthew R. Skelton received payments from drug or device companies?

CMS Open Payments shows $592 in general payments to Dr. Skelton from 17 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Matthew R. Skelton been practicing?

Dr. Skelton graduated from medical school in 2001, 25 years ago.

Does Dr. Matthew R. Skelton do research?

Dmand AI links 36 publications to Dr. Skelton, published from 2011 to 2025.

Who does Dr. Matthew R. Skelton publish with?

Dr. Skelton's most frequent co-authors are Blase N. Polite (2 shared papers), Neil Mark Richtand, MD (2 shared papers) and Kerin Bess Adelson, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Virginia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)